Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
Standard
Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit. / Blome, Christine; Radtke, Marc A; Eissing, Leah; Augustin, Matthias.
in: AM J CLIN DERMATOL, Jahrgang 17, Nr. 2, 04.2016, S. 163-169.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
AU - Blome, Christine
AU - Radtke, Marc A
AU - Eissing, Leah
AU - Augustin, Matthias
PY - 2016/4
Y1 - 2016/4
N2 - Health-related quality of life (HRQoL) is often markedly impaired in both adults and children with atopic dermatitis. The quality of life of the parents of infants or children with this chronic disease is also affected owing to problems such as itch-induced sleeping problems and treatment effort. As HRQoL is only partly associated with disease severity, both parameters should be evaluated in research and clinical practice. For the measurement of HRQoL, both skin- and disease-specific questionnaires are available in addition to generic instruments. In randomized controlled trials on atopic dermatitis, HRQoL is most commonly evaluated with the Dermatology Life Quality Index for use in adults and related questionnaires for children and families, such as the Children's Dermatology Life Quality Index. There is evidence that different treatment modalities may be effective in improving HRQoL in adults, children, and parents, which is supported by the patients' own evaluation of treatment benefit in an observational study.
AB - Health-related quality of life (HRQoL) is often markedly impaired in both adults and children with atopic dermatitis. The quality of life of the parents of infants or children with this chronic disease is also affected owing to problems such as itch-induced sleeping problems and treatment effort. As HRQoL is only partly associated with disease severity, both parameters should be evaluated in research and clinical practice. For the measurement of HRQoL, both skin- and disease-specific questionnaires are available in addition to generic instruments. In randomized controlled trials on atopic dermatitis, HRQoL is most commonly evaluated with the Dermatology Life Quality Index for use in adults and related questionnaires for children and families, such as the Children's Dermatology Life Quality Index. There is evidence that different treatment modalities may be effective in improving HRQoL in adults, children, and parents, which is supported by the patients' own evaluation of treatment benefit in an observational study.
KW - Adult
KW - Child
KW - Climatotherapy
KW - Cost of Illness
KW - Dermatitis, Atopic
KW - Female
KW - Glucocorticoids
KW - Humans
KW - Immunosuppressive Agents
KW - Infant
KW - Male
KW - Observational Studies as Topic
KW - Probiotics
KW - Quality of Life
KW - Randomized Controlled Trials as Topic
KW - Severity of Illness Index
KW - Surveys and Questionnaires
KW - Treatment Outcome
KW - Journal Article
KW - Review
U2 - 10.1007/s40257-015-0171-3
DO - 10.1007/s40257-015-0171-3
M3 - SCORING: Journal article
C2 - 26818063
VL - 17
SP - 163
EP - 169
JO - AM J CLIN DERMATOL
JF - AM J CLIN DERMATOL
SN - 1175-0561
IS - 2
ER -